MGLN

NASDAQ:MGLN

Magellan Health, Inc.

  • Stock

USD
0

Volume Today

832.18K

Avg: 143.02K

PE Ratio

605.27

PFCF: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
average inventory
47.67M
-
44.49M
6.66%
45.06M
1.28%
54.87M
21.77%
49.97M
8.93%
40.88M
18.19%
42.89M
4.91%
44.15M
2.93%
average payables
29.97M
-
53.39M
78.17%
75.21M
40.86%
91.06M
21.08%
84.97M
6.69%
73.19M
13.86%
80.25M
9.64%
112.90M
40.69%
average receivables
188.22M
-
295.95M
57.24%
391.18M
32.18%
517.70M
32.34%
633.77M
22.42%
708.42M
11.78%
823.06M
16.18%
816.78M
0.76%
book value per share
42.75
-
42.47
0.64%
42.88
0.96%
47.44
10.64%
54.71
15.32%
52.79
3.51%
57.66
9.23%
72.53
25.80%
capex per share
-2.39
-
-2.34
2.10%
-2.88
23.26%
-2.63
8.77%
-2.45
6.61%
-2.80
14.32%
-2.49
11.14%
-2.93
17.51%
capex to depreciation
-0.90
-
-0.68
23.65%
-0.70
1.69%
-0.57
17.52%
-0.49
13.84%
-0.51
4.05%
-0.46
10.76%
-0.64
38.40%
capex to operating cash flow
-0.35
-
-0.30
16.18%
-0.30
1.32%
-0.91
204.99%
-0.35
61.36%
-0.41
17.43%
-0.52
25.89%
-0.17
67.88%
capex to revenue
-0.02
-
-0.02
8.91%
-0.02
6.08%
-0.01
19.16%
-0.01
22.12%
-0.01
4.77%
-0.01
9.62%
-0.02
95.45%
cash per share
14.01
-
17.97
28.27%
17.61
2.04%
25.97
47.50%
30.40
17.06%
26.90
11.52%
27.21
1.18%
49.85
83.20%
days of inventory on hand
5.47
-
4.05
25.93%
4.19
3.40%
4.70
12.21%
2.68
42.93%
2.09
22.01%
2.37
13.12%
3.55
49.80%
days payables outstanding
4.73
-
6.58
39.21%
7.14
8.53%
7.62
6.74%
4.87
36.12%
3.70
24.11%
4.66
25.97%
11.25
141.51%
days sales outstanding
24.51
-
34.34
40.06%
34.03
0.89%
45.79
34.55%
41.31
9.78%
37.73
8.66%
45.38
20.27%
59.28
30.65%
debt to assets
0.34
-
0.46
33.88%
0.48
5.67%
0.55
13.47%
0.57
3.34%
0.57
0.04%
0.55
3.62%
0.44
19.08%
debt to equity
0.52
-
0.85
62.60%
0.94
11.00%
1.22
29.92%
1.32
7.74%
1.32
0.08%
1.21
8.01%
0.80
34.27%
dividend yield
earnings yield
0.08
-
0.05
40.05%
0.02
59.59%
0.04
132.04%
0.05
12.53%
0.02
64.29%
0.03
68.81%
0.00
93.57%
enterprise value
1.44B
-
1.62B
12.05%
1.68B
3.50%
2.06B
22.88%
2.71B
31.56%
1.87B
31.10%
2.25B
20.83%
1.63B
27.71%
enterprise value over ebitda
6.01
-
7.30
21.47%
9.14
25.14%
7.80
14.66%
9.78
25.32%
8.83
9.66%
9.07
2.72%
3.34
63.15%
ev to operating cash flow
7.89
-
7.67
2.76%
7.00
8.67%
30.86
340.64%
16.69
45.93%
11.32
32.17%
19.46
71.93%
3.62
81.42%
ev to sales
0.41
-
0.43
5.68%
0.36
15.35%
0.43
16.79%
0.46
8.99%
0.26
45.00%
0.31
23.44%
0.36
13.06%
free cash flow per share
4.38
-
5.57
27.08%
6.74
20.97%
0.25
96.28%
4.50
1,693.69%
3.97
11.90%
2.29
42.34%
14.56
536.49%
free cash flow yield
0.07
-
0.09
26.83%
0.11
17.78%
0.00
96.95%
0.05
1,297.98%
0.07
49.51%
0.03
58.08%
0.18
501.22%
graham net net
-0.75
-
-7.34
882.42%
-8.78
19.54%
-11.10
26.50%
-19.52
75.76%
-18.54
5.01%
-14.22
23.32%
14.53
202.24%
graham number
66.73
-
51.56
22.74%
33.37
35.27%
59.07
77.01%
76.23
29.03%
34.34
54.94%
54.69
59.25%
16.00
70.74%
income quality
1.46
-
2.66
81.77%
7.61
186.48%
0.86
88.75%
1.47
71.92%
6.82
362.98%
2.07
69.60%
1.18
43.11%
intangibles to total assets
0.32
-
0.33
5.38%
0.36
9.16%
0.38
4.14%
0.43
13.46%
0.42
2.64%
0.38
8.63%
0.28
25.98%
interest coverage
56.06
-
17.66
68.49%
12.22
30.83%
15.48
26.71%
6.21
59.90%
2.22
64.24%
3.24
45.72%
11.94
269.18%
interest debt per share
0.11
-
0.28
149.60%
0.26
4.38%
0.44
66.14%
1.11
153.19%
1.45
30.57%
29.65
1,939.53%
25.96
12.45%
inventory turnover
66.68
-
90.03
35.01%
87.08
3.28%
77.60
10.88%
135.98
75.23%
174.36
28.23%
154.13
11.60%
102.89
33.24%
invested capital
0.49
-
0.34
30.10%
market cap
1.62B
-
1.60B
1.15%
1.53B
4.30%
1.74B
13.77%
2.25B
29.15%
1.39B
38.51%
1.90B
36.95%
2.14B
12.58%
net current asset value
386.63M
-
206.95M
46.47%
94.81M
54.19%
-24.70M
126.05%
-197.39M
699.11%
-146.59M
25.74%
-21.35M
85.44%
666.51M
3,222.28%
net debt to ebitda
-0.73
-
0.07
109.96%
0.77
957.67%
1.19
53.65%
1.64
38.10%
2.27
38.48%
1.44
36.78%
-1.04
172.19%
net income per share
4.63
-
2.78
39.93%
1.15
58.49%
3.27
183.19%
4.72
44.38%
0.99
78.96%
2.31
132.19%
0.16
93.19%
operating cash flow per share
6.77
-
7.91
16.80%
9.62
21.65%
2.88
70.09%
6.95
141.71%
6.77
2.65%
4.78
29.42%
17.48
265.89%
payables turnover
77.20
-
55.45
28.17%
51.10
7.86%
47.87
6.32%
74.93
56.54%
98.74
31.77%
78.38
20.62%
32.46
58.59%
receivables turnover
14.89
-
10.63
28.60%
10.73
0.89%
7.97
25.68%
8.84
10.84%
9.67
9.48%
8.04
16.85%
6.16
23.46%
research and ddevelopement to revenue
return on tangible assets
0.10
-
0.05
48.94%
0.02
58.97%
0.05
128.97%
0.07
30.88%
0.01
78.63%
0.03
109.64%
0.00
94.27%
revenue per share
131.08
-
140.89
7.48%
184.89
31.24%
208.66
12.85%
250.23
19.92%
300.39
20.05%
295.32
1.69%
177.55
39.88%
roe
0.11
-
0.07
39.54%
0.03
58.88%
0.07
155.96%
0.09
25.20%
0.02
78.20%
0.04
112.58%
0.00
94.59%
roic
0.10
-
0.05
44.48%
0.02
65.72%
0.05
155.07%
0.06
33.27%
0.02
70.43%
0.03
84.61%
-0.04
214.79%
sales general and administrative to revenue
shareholders equity per share
42.75
-
42.47
0.64%
42.88
0.96%
47.44
10.64%
54.71
15.32%
52.79
3.51%
57.66
9.23%
72.53
25.80%
stock based compensation to revenue
0.01
-
0.01
80.11%
0.01
1.54%
0.01
29.40%
0.01
13.41%
0.00
39.86%
0.00
11.60%
0.01
56.09%
tangible asset value
598.59M
-
433.73M
27.54%
311.42M
28.20%
171.43M
44.95%
1.92M
98.88%
35.26M
1,738.58%
212.28M
501.98%
916.50M
331.74%
tangible book value per share
22.13
-
16.25
26.55%
12.52
22.93%
7.40
40.95%
0.08
98.89%
1.45
1,661.86%
8.76
504.61%
35.55
305.98%
working capital
513.09M
-
581.71M
13.37%
373.45M
35.80%
226.42M
39.37%
591.05M
161.04%
648.27M
9.68%
762.90M
17.68%
1.42B
85.98%

All numbers in USD (except ratios and percentages)